Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $396.7350 (2.78%) ($396.7350 - $396.7350) on Tue. Feb. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.77% (three month average) | RSI | 64 | Latest Price | $396.7350(2.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 2.2% a day on average for past five trading days. | Weekly Trend | REGN advances 5.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(48%) IVW(41%) IWF(41%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.885% in a week (0% probabilities). VIXM(-24%) VXX(-10%) TLT(-5%) TIP(-1%) SHY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.885% (StdDev 1.77%) | Hourly BBV | 1.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $385.41(2.94%) | 10 Day Moving Average | $365.13(8.66%) | 20 Day Moving Average | $364.79(8.76%) | To recent high | 0% | To recent low | 18% | Market Cap | $42.065b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |